- Title
- Germline Pathogenic Variants in MUTYH Are Associated With Inferior Survival After Hematopoietic Cell Transplantation in Patients With Hematologic Malignancies or Disorders
- Creators
- Maryam Rafati - National Cancer InstituteYoujin Wang - National Cancer InstituteAshwin L Koppayi - Northwestern UniversitySharon A Savage - National Cancer InstituteLucy A Godley - Northwestern UniversityKirsten M Williams - Children's Healthcare of AtlantaChristopher Porter - Children's Healthcare of AtlantaKristine Jones - Leidos (United States)Belynda Hicks - Leidos (United States)Stephen R Spellman - National Marrow Donor ProgramMeilun He - National Marrow Donor ProgramRasha Atshan - Medical College of WisconsinCaidon Iwuagwu - National Cancer InstituteYung-Tsi Bolon - CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, Minnesota, USAEsteban Arrieta-Bolaños - Essen University HospitalJennifer N Saultz - Oregon Health & Science UniversityCara L Benjamin - University of MiamiStephanie J Lee - Medical College of WisconsinWael Saber - Medical College of WisconsinShahinaz M Gadalla - National Cancer Institute
- Publication Details
- American journal of hematology, Vol.100(12)
- Publisher
- WILEY; HOBOKEN
- Number of pages
- 6
- Grant note
- W81XWH-19-1-0241 / NCI NIH HHS 75N910D00024 / NCI NIH HHS U24CA076518 / U.S. Public Health Service Congressionally Directed Medical Research Programs
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
- Language
- English
- Resource Type
- Journal article
- PMID
- 41042026
- Record Identifier
- 991032825976802976
Journal article
Germline Pathogenic Variants in MUTYH Are Associated With Inferior Survival After Hematopoietic Cell Transplantation in Patients With Hematologic Malignancies or Disorders
American journal of hematology, Vol.100(12)
2025-10-03
PMID: 41042026
Metrics
1 Record Views